Chloracne is the major skin symptom caused by dioxin intoxication. Dioxin activates the aryl 14 hydrocarbon receptor (AHR)-cytochrome p450 1A1 (CYP1A1) system, generates oxidative 15 stress, and induces hyperkeratinization of keratinocytes and sebocytes leading to chloracne. 
Introduction 28
Health problems associated with environmental pollutants are an important issue. 29 Environmental polycyclic aromatic hydrocarbons such as 2,3,7,8-tetrachlorodibenzo-p-dioxin, 30 polychlorinated dibenzofuran, and benzo(a)pyrene (BaP) are high-affinity ligands for aryl 31 hydrocarbon receptor (AHR) or dioxin receptor [1] [2] [3] [4] . These chemical compounds strongly 32 activate AHR, generate reactive oxygen species (ROS), and induce the production of 33 inflammatory cytokines in various tissues including skin [1] [2] [3] [4] . To maintain cellular 34 homeostasis, excessive production of ROS should be neutralized or minimized by cellular 35 antioxidants including antioxidative enzymes such as heme oxygenase-1 (HMOX1) and 36 Among the cutaneous symptoms caused by dioxin, chloracne is one of the major ones, 48 causing significant deterioration in the quality of daily life [15] [16] [17] [18] . Chloracne has a 49 characteristic skin distribution, with it frequently affecting retroauricular and malar areas of the 50 face, ear lobes, and groin, whereas the nose and perioral area are typically spared [16] [17] [18] [19] [20] . The 51 severity of chloracne is also correlated with blood dioxin level [16] . 52 The pathology of chloracne is characterized by hyperkeratinization of the interfollicular 53 epidermis, hyperproliferation and hyperkeratinization of hair follicle cells, gradual loss of 54 sebocytes with shrinkage of sebaceous glands, and infundibular dilatation, eventually leading to 55 comedo formation [3, [16] [17] [18] As dioxin is very stable and persistent, the metabolizing process by CYP1A1 generates high 74 levels of ROS (Fig. 1) the NRF2-HMOX1 antioxidative system and inhibit AHR-mediated ROS production (Fig. 1) 
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The authors declare that they have no conflicts of interest. inhibitors of AHR-CYP1A1 signaling. On the other hand, they activate nuclear factor-erythroid 170 2-related factor-2 (NRF2). NRF2 is a master switch for the cellular antioxidative system. 
